Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.

• Main Authors: Sauman Singh-Phulgenda (Author), Rishikesh Kumar (Author), Prabin Dahal (Author), Abdalla Munir (Author), Sumayyah Rashan (Author), Rutuja Chhajed (Author), Caitlin Naylor (Author), Brittany J Maguire (Author), Niyamat Ali Siddiqui (Author), Eli Harriss (Author), Manju Rahi (Author), Fabiana Alves (Author), Shyam Sundar (Author), Kasia Stepniewska (Author), Ahmed Musa (Author), Philippe J Guerin (Author), Krishna Pandey (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis which can occur after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL endemic areas. We conducted a systematic scoping review to assess the characteristics of published...